Dual-action drug approved for use in advanced breast cancer.
作者信息
McBride Deborah
出版信息
ONS Connect. 2007 Jun;22(6):19.
PMID:17598617
Abstract
摘要
相似文献
1
Dual-action drug approved for use in advanced breast cancer.双作用药物获批用于晚期乳腺癌。
ONS Connect. 2007 Jun;22(6):19.
2
Approved agents for metastatic breast cancer.转移性乳腺癌的获批药物。
Semin Oncol. 2011 Jun;38 Suppl 2:S3-10. doi: 10.1053/j.seminoncol.2011.04.003.
3
Femara approved as first-line breast cancer therapy.法乐通获批成为一线乳腺癌治疗药物。
FDA Consum. 2001 May-Jun;35(3):5.
4
New treatment for advanced breast cancer.晚期乳腺癌的新疗法。
FDA Consum. 2002 Jul-Aug;36(4):6.
5
FDA approves new drug for specific type of advanced breast cancer.美国食品药品监督管理局批准用于特定类型晚期乳腺癌的新药。
Mayo Clin Womens Healthsource. 2007 Oct;11(10):3.
6
Bioregulatory niches in breast cancer.乳腺癌中的生物调节微环境。
Clin Breast Cancer. 2006 Aug;7(3):200. doi: 10.3816/CBC.2006.n.033.
7
Better prioritization may speed approval of adjuvant therapies in breast cancer.更好地确定优先次序可能会加快乳腺癌辅助治疗的批准速度。
J Natl Cancer Inst. 2008 Jun 18;100(12):842-4. doi: 10.1093/jnci/djn197. Epub 2008 Jun 10.
8
Swimming upstream: an advocate reflects on cancer research and social realities.逆流而上：一位倡导者对癌症研究与社会现实的反思
J Clin Oncol. 2008 Jun 1;26(16):2783-6. doi: 10.1200/JCO.2008.17.4532.
9
FDA advisors recommend approval of taxol for node-positive breast cancer.美国食品药品监督管理局顾问建议批准将紫杉醇用于治疗淋巴结阳性乳腺癌。
Oncologist. 1999;4(5):430-1.
10
Monoclonal antibody approved for metastatic breast cancer.已获批用于转移性乳腺癌的单克隆抗体。
Oncology (Williston Park). 1998 Dec;12(12):1727.
Zotero 插件